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IsaB Inhibits Autophagic Flux to Promote Host
Transmission of Methicillin-Resistant Staphylococcus
aureus
Pei-Feng Liu1,2,7, Jin-Shiung Cheng3,7, Cheng-Len Sy3,7, Wei-Chun Huang4,5, Hsiu-Chen Yang1,
Richard L. Gallo2,6, Chun-Ming Huang2 and Chih-Wen Shu1
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a major nosocomial pathogen that is
widespread in both health-care facilities and in the community at large, as a result of direct host-to-host
transmission. Several virulence factors are associated with pathogen transmission to naive hosts. Immunodo-
minant surface antigen B (IsaB) is a virulence factor that helps Staphylococcus aureus to evade the host defense
system. However, the mechanism of IsaB on host transmissibility remains unclear. We found that IsaB expression
was elevated in transmissible MRSA. Wild-type isaB strains inhibited autophagic ﬂux to promote bacterial survival
and elicit inﬂammation in THP-1 cells and mouse skin. MRSA isolates with increased IsaB expression showed
decreased autophagic ﬂux, and the MRSA isolate with the lowest IsaB expression showed increased autophagic
ﬂux. In addition, recombinant IsaB rescued the virulence of the isaB deletion strain and increased the group A
streptococcus (GAS) virulence in vivo. Together, these results reveal that IsaB diminishes autophagic ﬂux,
thereby allowing MRSA to evade host degradation. These ﬁndings suggest that IsaB is a suitable target for
preventing or treating MRSA infection.
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INTRODUCTION
For several decades, methicillin-resistant Staphylococcus
aureus (MRSA) has been recognized as a leading cause of
nosocomial infections worldwide (Chatterjee and Otto, 2013;
Hogea et al., 2014). MRSA infections occur predominantly in
hospitals, in which case they are called hospital-acquired
MRSA; however, the incidence of community-acquired MRSA
infections has been increasing (Jappe et al., 2008; Otto, 2010;
Xia et al., 2013). MRSA can spread to the bloodstream and
cause sepsis, a leading cause of shock and circulatory
collapse (Tarkowski et al., 2001). MRSA can also spread to
other organs, including the lung, kidney, liver, spleen, heart,
and bones, resulting in severe infections such as urethritis,
pneumonia, endocarditis, and osteomyelitis (Haim et al.,
2010). MRSA is becoming increasingly difﬁcult to treat
because multidrug-resistant strains of MRSA are on the rise,
leading to high mortality rates in humans (Westling, 2009).
The increasing morbidity and mortality associated with MRSA
infections have motivated researchers to make MRSA
prevention and therapy a priority. Transmission between
hosts is a vital aspect of the biology of any commensal or
pathogenic microorganism (Massey et al., 2006). For example,
pathogenic bacteria use virulence factors that attack or allow
evasion of the host antimicrobial defense system, promoting
bacterial survival and allowing infection of the host (Liu et al.,
2009; Orvedahl and Levine, 2009; Lo et al., 2011; Ogawa
et al., 2011; Otto, 2012; Kassegne et al., 2014). In addition,
virulence factors may be required for the transmission of
pathogens to naive hosts (Wickham et al., 2007).
Autophagy is a “self-eating” pathway that generates
autophagosomes and delivers abnormal organelles or mis-
folded proteins to lysosomes for degradation during stress or
nutrient deprivation (Mizushima et al., 2008). Autophagy
serves as an antimicrobial defense mechanism that eliminates
invading bacteria (a process called xenophagy) and has a
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crucial role in host cell resistance to infection (Knodler and
Celli, 2011; Parihar et al., 2014). Although the precise
mechanisms of autophagy on bacteria remain unclear,
autophagosomes and phagosomes are involved in recruiting
intracellular bacteria into lysosomes for bulk degradation
(Levine et al., 2011; Petruccioli et al., 2012). In contrast,
invading bacteria express virulence factors that attenuate host
autophagic ﬂux and allow escape from host attack: e.g., IcsB
of Shigella ﬂexneri and the deubiquitinase SseL of Salmonella
Typhimurium (Ogawa et al., 2005) (Mesquita et al., 2012).
Furthermore, S. ﬂexneri expresses the T3SS effector IcsB that
interferes with the binding between the surface protein VirG
and the host protein ATG5 and thereby allows S. ﬂexneri to
avoid targeting by host autophagy (Ogawa et al., 2005). Ssel,
a deubiquitinase of Salmonella, reduces ubiquitinated
aggregates and eliminates recruitment of the autophagy
adaptor sequestosome 1 (SQSTM1) that in turn evades host
autophagy degradation and promotes Salmonella replication
in cells (Mesquita et al., 2012). Interestingly, S. aureus
employs autophagosomes to replicate in human cervical
cancer HeLa cells or ﬁbroblast cells (Schnaith et al., 2007),
indicating that autophagy is detrimental to these host cells
during S. aureus infection. Nevertheless, autophagy is
induced to degrade intracellular bacteria and serves as a
safeguard for host cells during S. aureus infection (Amano
et al., 2006; Mauthe et al., 2012), suggesting that the role of
autophagy in S. aureus infections is not fully understood.
S. aureus immunodominant surface antigen B (IsaB) is
classiﬁed as both a secreted and a cell surface–associated
virulence factor, and it elicits an immune response during
septicemia (Mackey-Lawrence et al., 2009). Analysis of global
transcripts showed that isaB expression is induced in response
to certain conditions and factors such as the presence of
glucose, human serum, plasma (Mackey-Lawrence and
Jefferson, 2013a), bioﬁlms, neutrophil exposure, anaerobic
conditions, bacteremia, and infections, and following
internalization by human epithelial cells, suggesting a role
in immune evasion and virulence (Resch et al., 2005; Voyich
et al., 2005; Fuchs et al., 2007; Garzoni et al., 2007).
However, the role of IsaB in the autophagy of MRSA-infected
cells and in the transmission of MRSA is not deﬁned. In this
study, we found that the expression of the IsaB virulence
factor was elevated in transmissible MRSA. IsaB was involved
in susceptibility to MRSA infection and inﬂammation via
inhibition of autophagic ﬂux in both human macrophage-like
THP-1 cells and in vivo. Moreover, group A streptococcus
(GAS), an invading pathogen that is easily degraded by host
autophagy, became more virulent in cells treated with
recombinant IsaB. Our study suggests that IsaB is a suitable
target for preventing and treating MRSA infection.
RESULTS
IsaB expression is induced in transmissible MRSA strain in vivo
To compare the virulence of MRSA with and without host
transmissibility, transmissible MRSA strain was isolated. After
one host transmission of MRSA (MRSA(1)), severe ear
inﬂammation (Figure 1a) and increased secretion of macro-
phage inﬂammatory peptide-2 from skin tissue were observed
in mice at day 5 after infection (Figure 1b), in addition to
4100-fold increase in bacterial colonization of the ear skin
(Figure 1c) over infection with parental MRSA (MRSA(0)).
These results suggest that after host transmission MRSA
became more virulent and caused severe skin inﬂammation
and bacterial colonization. Because expression of IsaB is
increased during S. aureus infection (Mackey-Lawrence
and Jefferson, 2013a), we examined IsaB expression in
transmissible MRSA by immunoblotting with the antibody
generated against puriﬁed recombinant IsaB (Supplementary
Figure S1 online). The recombinant IsaB was validated by
sequencing using nano-liquid chromatography linear trap
quadrupole tandem mass spectrometry. Thirty-eight peptides
were fully sequenced, and these matched well with the
internal amino acids of MRSA IsaB (Supplementary Table S1).
We found that the expression level of IsaB was increased in
transmissible MRSA(1) compared with that in parental MRSA
(0) (Figure 1d). These results indicate that the virulence factor
IsaB may be involved in MRSA host transmissibility.
IsaB diminishes autophagic ﬂux to enhance bacterial survival in
cells
Autophagy has a crucial role in the clearance of invading
bacteria from host cells (Levine et al., 2011; Gong et al.,
2012). To examine the potential mechanisms of virulence
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Figure 1. Transmissible MRSA252 induces immunodominant surface antigen
B (IsaB) expression and inﬂammation in vivo. (a) The right ears of mice were
injected intradermally with MRSA(0) or MRSA(1) (1× 107 colony-forming units
(CFUs)). Ear thickness was measured and calculated as a percentage,
compared with the phosphate-buffered saline (PBS)–injected control, on days
1, 2, and 5 after methicillin-resistant Staphylococcus aureus (MRSA) injection.
Representative images of skin inﬂammation are shown. Bar=1 cm. (b)
Macrophage inﬂammatory protein-2 (MIP-2) production in mice infected with
MRSA(1) was measured by ELISA and normalized to that in mice infected with
MRSA(0). (c) The infected ears on day 5 were homogenized for counting
MRSA colonies. Data are expressed as mean± SEM (n=8). (d) The samples in
c were subjected to immunoblotting. An arrow indicates IsaB protein that has
a molecular weight of 20 kDa.
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factor IsaB on MRSA transmissibility, wild-type (WT) and
isogenic isaB deletion strains were used to infect human
HeLa cells harboring GFP-MAP1LC3. Autophagy induction
increases the number and intensity of small MAP1LC3-II
puncta, whereas blocking the downstream steps of autopha-
gosome or lysosome development not only increases the
surface area and intensity of MAP1LC3-II puncta in the
cytoplasm but also causes them to aggregate around the
nuclear membrane (Zhang et al., 2007). We included
rapamycin and baﬁlomycin A1 (BafA1) as controls for
autophagic ﬂux induction and inhibition, respectively
(Figure 2a and b). In contrast, WT isaB strain apparently
increased the surface area and intensity of GFP-MAP1LC3-II
puncta in the cells (Figure 2a). HeLa cells harboring RFP-GFP-
MAP1LC3 were further used to inspect the role of IsaB on
autophagic ﬂux. Because green ﬂuorescent protein (GFP) is
quenched in acidic environments, such as that in an
autolysosome, the RFP+GFP+ puncta and RFP+GFP− puncta
were considered to be autophagosomes and autolysosomes,
respectively (Zhou et al., 2012). The cells infected with the
WT strain had relatively fewer autolysosomes (RFP+GFP−)
compared with the cells infected with isaB deletion strain
(Figure 2b and c). Next, we examined MAP1LC3-II and
SQSTM1 degradation in infected THP-1 cells cultured with or
without chloroquine (an autophagic ﬂux inhibitor) to deter-
mine the effect of IsaB on autophagic ﬂux in host cells, as
described previously (Liu et al., 2014). MAP1LC3-II and
SQSTM1 proteins were accumulated in THP-1 cells when
infected with WT strain (Figure 2d and e), indicating that IsaB
may inhibit autophagic ﬂux in host cells. To determine
colocalization between bacteria and lysosomes, HeLa cells
expressing the lysosomal marker Lamp1-RFP (Figure 3a) were
infected with bacteria that were labeled with SYTO green
ﬂuorescent dye. The number of intracellular bacteria was
increased in HeLa cells that were pretreated with BafA1,
whereas the percentage of lysosomes colocalized with
bacteria was reduced in these cells (Figure 3a and b).
Furthermore, the survival of isaB deletion strain in THP-1
cells was signiﬁcantly decreased (Figure 3c and d). The
decreased bacterial survival of isaB deletion strain was
recovered in both cells by pretreatment with rapamycin and
BafA1 (Figure 3c–e). However, silencing Atg5 and Ulk1,
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Figure 2. Immunodominant surface antigen B (IsaB) is involved in autophagic ﬂux inhibition in cells. (a) HeLa cells harboring GFP-MAP1LC3 or (b) RFP-GFP-
MAP1LC3 were infected with wild-type (WT) Staphylococcus aureus or an isogenic deletion mutant (ΔisaB) (multiplicity of infection (MOI) of 200) for 6 hours to
observe GFP-MAP1LC3 puncta and autophagic ﬂux using confocal microscopy. Rapamycin (Rapa; 0.5 μM) or baﬁlomycin A1 (BafA1; 100 nM) were used as
control for autophagy induction and inhibition, respectively. Bar=10 μm. (c) The percentages of autophagosomes (RFP+GFP+) and autolysosomes (RFP+GFP−) in
each cell as in b were quantiﬁed from a pool of at least 10 images. (d) Human macrophage-like THP-1 cells were infected with WT S. aureus or an isogenic
deletion mutant (ΔisaB) (MOI of 200) for 6 hours in the presence or absence of 20 μM chloroquine (CQ). The accumulation of sequestosome 1 (SQSTM1) and
MAP1LC3-II in infected THP-1 cells was examined by immunoblotting. (e) The quantiﬁcation of SQSTM1 protein levels and autophagic ﬂux is shown. The results
are expressed as mean± SEM from three independent experiments. GFP, green ﬂuorescent protein; MAP1LC3, microtubule-associated proteins 1A/1B light
chain 3. P-values lower than 0.05 were considered signiﬁcant (*Po0.05).
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which are both essential genes for autophagosome formation,
did not restore bacterial survival of isaB deletion strain in
THP-1 cells (Supplementary Figure S2), implying that IsaB
may block autophagic ﬂux and allow bacteria to survive in
cells. We also found that tumor necrosis factor-α (TNF-α)
secretion was diminished in THP-1 cells infected with the isaB
deletion strain compared with the WT strain (Figure 3f). The
mRNA levels of Tnf-α and Il-8 were reduced in the cells
infected with isaB deletion mutant (Figure 3g), suggesting that
IsaB may diminish autophagic ﬂux, enhance the survival of
S. aureus, and thereby elicit inﬂammation in host. More
interestingly, clinical MRSA isolates expressing higher levels
of IsaB accumulated more SQSTM1 protein and displayed
less autophagic ﬂux in THP-1 cells than MRSA (C1) that had
the lowest IsaB expression level out of the ﬁve MRSA clinical
isolates tested in this study (Figure 4). Moreover, production of
the inﬂammatory cytokine TNF-α and mRNA levels of Tnf-α
and Il-8 in the infected THP-1 cells were negatively
correlated with autophagic activity (Figure 4), supporting
the notion that IsaB may reduce autophagic ﬂux and thereby
allow MRSA to survive in the host cells. In addition to the
role of bacterial virulence factors in autophagy, they are also
involved in the induction of immune cell death that may be
important for bacterial survival and escape from host
immune defense (Haim et al., 2010; Sumpter and Levine,
2010). Indeed, apoptosis was increased in macrophages
infected with strains expressing high levels of IsaB
(Supplementary Figure S3a and b). In contrast, recombinant
IsaB had no effect on apoptosis in macrophages
(Supplementary Figure S3c), suggesting that IsaB may have
an additional role in cytotoxicity when bacteria are
internalized into cells.
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Figure 3. Autophagic ﬂux inhibition increases the viability of Staphylococcus aureus in host cells. (a) HeLa cells harboring Lamp1-RFP (red) were infected with
SYTO (green)-labeled wild-type (WT) S. aureus or an isogenic deletion mutant (ΔisaB) (multiplicity of infection (MOI) of 200) for 5 hours in the absence or
presence of baﬁlomycin A1 (BafA1; 100 nM) or rapamycin (Rapa; 0.5 μM). The cells were then ﬁxed and observed under confocal microscopy. Bar=10 μm. (b)
Colocalization of bacteria and Lamp1 in cells as in a was quantiﬁed. Ctrl, control. (c) Human macrophage-like THP-1 cells were infected with SYTO (green)-
labeled bacteria (MOI of 200) for 6 hours with or without BafA1 (100 nM) or rapamycin (0.5 μM). The infected cells were harvested to determine the amount of
bacteria in the host cells using ﬂow cytometer. (d) The percentage of bacteria in cells was quantiﬁed by FlowJo software and analyzed by Prism 5.0. (e) Colony
formation by the cells infected with bacteria (MOI of 200) for 6 hours in the presence or absence of BafA1 was quantiﬁed. (f) The secretion of the inﬂammatory
cytokine tumor necrosis factor-α (TNF-α) and (g) the mRNA levels of Tnf-α and Il-8 in infected THP-1 cells were determined by ELISA and real-time PCR,
respectively. The results are expressed as mean± SEM from three independent experiments. CFU, colony-forming unit. P-values lower than 0.05 were considered
signiﬁcant (*Po0.05, **Po0.01, and ***Po0.001).
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The WT isaB strain inhibits autophagic ﬂux and increases
survival in vivo
To examine the involvement of IsaB in MRSA virulence
in vivo, mice ears were injected with a WT isaB strain or
deletion strain, and skin lesions were used as an indication of
inﬂammation. At day 3, the ears injected with isaB deletion
strain displayed signiﬁcantly less inﬂammation than mice
whose ears were injected with the WT strain (Figure 5a, WT).
Next, the mouse ears injected with either the WT strain or isaB
deletion strain were excised and homogenized to assess
bacterial colonization (Figure 5b), and immunoblotting of
MAP1LC3 (microtubule-associated proteins 1A/1B light chain
3) and SQSTM1 was conducted to assess host autophagic ﬂux
(Figure 5c and d). The survival of isaB deletion strain was
much lower than that of the WT strain in vivo (Figure 5b). In
contrast to mouse ears infected with the isaB deletion mutant,
those infected with the WT strain showed increased
accumulation of SQSTM1 and lapidated MAP1LC3-II, further
conﬁrming that IsaB inhibits host autophagic ﬂux in vivo
(Figure 5c and d). The lesion size and bacterial survival in
mouse dorsal skin was also signiﬁcantly reduced in the mice
injected with the isaB deletion strain (Figure 5e and f). These
results further support the notion that IsaB is involved in
modulating autophagic ﬂux to promote bacterial survival and
elicit the host inﬂammatory response.
Recombinant IsaB inhibits autophagic ﬂux in vitro and enhances
bacterial colonization in vivo
To examine the role of IsaB on autophagic ﬂux, cells were
treated with recombinant MRSA IsaB and then assessed for
MAP1LC3-II puncta accumulation, with BafA1 used as the
positive control. We found that treatment with recombinant
IsaB led to the accumulation of MAP1LC3-II puncta in a dose-
dependent manner (Figure 6a). Similarly, recombinant IsaB
resulted in signiﬁcant accumulation of autophagic markers,
including GFP-MAP1LC3-II, GFP, and SQSTM1, in infected
mouse embryonic ﬁbroblast cells stably expressing GFP-
MAP1LC3 (Mizushima et al., 2010) (Figure 6b). Interestingly,
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Figure 4. Immunodominant surface antigen B (IsaB) expression in clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates is associated with
autophagy and inﬂammation in THP-1 cells. (a) Clinical MRSA isolates were lysed to examine IsaB protein levels by immunoblotting. (b) Human macrophage-
like THP-1 cells were infected with clinical MRSA isolates (multiplicity of infection (MOI) of 10) for 6 hours in the presence (+) or absence (− ) of 20 μM
chloroquine (CQ) for 2 hours before harvesting. Cells were then lysed to examine sequestosome 1 (SQSTM1) and MAP1LC3-II protein levels by immunoblotting.
Because the clinical MRSA isolate C1 shows the lowest IsaB expression of the ﬁve tested clinical MRSA isolates, the protein levels of (c) SQSTM1 and
(d) MAP1LC3-II in the infected cells were quantiﬁed using the C1-infected cells as a control. MAP1LC3, microtubule-associated proteins 1A/1B light chain 3.
(e) Colony formation, (f) secretion of tumor necrosis factor-α (TNF-α), and (g) the mRNA levels of Tnf-α and Il-8 in infected THP-1 cells were determined by ELISA
and real-time PCR, respectively. The results are expressed as mean± SEM from three independent experiments. CFU, colony-forming unit. P-values lower than
0.05 were considered signiﬁcant (*Po0.05, **Po0.01, and ***Po0.001).
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the decreased lesion size in the mice skin that were infected
with the isaB deletion strain was signiﬁcantly restored when
the mice were injected with recombinant IsaB, whereas
recombinant GFP had little effect on virulence reconstitution
(Figure 6c). Similar results were observed for bacterial colony
formation (Figure 6d). Because intracellular GAS are degraded
by host autophagy within 5 hours after infection (Yamaguchi
et al., 2009), we hypothesized that exogenous MRSA IsaB
might promote GAS virulence. Indeed, the lesion size and
number of GAS colonies were signiﬁcantly increased when
mice were injected with recombinant IsaB compared with
injections with recombinant GFP (Figure 6e and f), revealing
that the virulence factor IsaB may inhibit autophagic ﬂux and
thereby eradicate bacterial degradation in vivo. Furthermore,
the number of MRSA(1) colonies and lesion size in the ears
and dorsal skin of IsaB-immunized mice were signiﬁcantly
lower than in GFP-immunized mice (Supplementary Figures
S4 and S5). These results show that IsaB is a potential vaccine
for the MRSA.
DISCUSSION
MRSA infection remains a signiﬁcant threat to human health
in the second decade of the twenty-ﬁrst century. It is widely
accepted that increased virulence of MRSA is associated with
increased transmissibility (Massey et al., 2006). Virulence
factors of MRSA strains have been reported to attenuate
antimicrobial systems in host cells (Kraus and Peschel, 2008).
Although several antibiotics are used to treat MRSA infection,
multidrug-resistant strains of MRSA are a growing threat to
public health (Han et al., 2007). Therefore, increasing our
understanding of how MRSA virulence factors counteract host
antimicrobial mechanisms can provide critical insight into the
pathogenesis of MRSA and may advance preventive and
therapeutic strategies. In this study, we report the following
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on day 3 after injection. The results are expressed as mean± SEM. P-values lower than 0.05 were considered signiﬁcant (*Po0.05, **Po0.01, and ***Po0.001).
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ﬁndings. First, the level of IsaB is elevated in transmissible
MRSA(1) that is more virulent than parental MRSA(0). Second,
elevated IsaB inhibits host autophagic ﬂux and increases MRSA
survival, thereby eliciting inﬂammation in both cell culture and
animal models. Third, recombinant IsaB inhibits autophagic
ﬂux and increases host susceptibility to infection with GAS.
These ﬁndings shed light on the virulence mechanisms of IsaB
in skin pathogenesis during MRSA infection.
Autophagy is an innate antimicrobial defense mechanism
that eliminates intracellular bacteria and reduces excessive
inﬂammation in host cells (Petruccioli et al., 2012). Some
bacteria have developed strategies to avoid degradation by
host autophagic responses. These bacteria express virulence
factors that block autophagy by inhibiting essential molecules
or steps in autophagy, such as the ATG protein, autophagic
recognition (Yoshikawa et al., 2009; Sumpter and Levine,
2010), and membrane (autophagosome and lysosome) fusion
(Gong et al., 2012). However, the role of autophagy can be
either beneﬁcial or detrimental to host cells during S. aureus
infection. S. aureus becomes trapped and is degraded in
autophagosomes in human osteosarcoma U2OS cells
(Mauthe et al., 2012), but accessory gene regulator (agr), a
virulence factor, is involved in inducing autophagosomes to
form a niche for S. aureus replication in HeLa cells (Schnaith
et al., 2007). Our current data show that the level of IsaB is
elevated in transmissible MRSA and that IsaB may negatively
regulate autophagic ﬂux in human macrophage-like THP-
-1 cells. Clinical MRSA isolates expressing high levels of IsaB
also display reduced autophagic ﬂux, increased survival, and
elevated inﬂammatory cytokine production, in line with
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Figure 6. Recombinant immunodominant surface antigen B (IsaB) diminishes autophagic ﬂux and reconstitutes the virulence of the isaB-deﬁcient strain and
group A streptococcus (GAS). (a) HeLa cells harboring GFP-MAP1LC3 were treated with recombinant IsaB for 6 hours and ﬁxed to determine the effect of IsaB on
GFP-MAP1LC3-II puncta, using ﬂorescence microscopy. Baﬁlomycin A1 (BafA1; 100 nM) is used as a control for autophagic ﬂux inhibition. Bar= 10 μm. (b)
Mouse embryonic ﬁbroblast (MEF) cells stably harboring GFP-MAP1LC3 were treated with recombinant IsaB for 6 hours. Protein levels of GFP-MAP1LC3-II, green
ﬂuorescent protein (GFP), and sequestosome 1 (SQSTM1) in treated cells were determined by immunoblotting. Protein levels were normalized with ACTB and are
shown as quantiﬁed in the right panel. (c) Mice were injected with the isaB deletion strain (1× 107 colony-forming units (CFUs)) and 50 μg of recombinant
methicillin-resistant Staphylococcus aureus (MRSA) IsaB (R-IsaB±ΔisaB) or GFP (R-GFP±ΔisaB). Lesion sizes were quantiﬁed on day 3 after injection using the
ImageJ software (n=4). Bar=0.5 cm. (d) Bacterial survival on day 3 after injection was quantiﬁed in agar plates. (e) Live GAS NZ131 (1× 107 CFUs) mixed with
50 μg of recombinant IsaB (R-IsaB+GAS) or GFP (R-GFP+GAS) was subcutaneously injected into the dorsal skin of mice. Lesion sizes and (f) bacterial survival on
day 3 after injection were quantiﬁed using the ImageJ software. Representative images of dorsal skin lesions are shown. Bar=0.5 cm. The results are expressed as
mean± SEM. P-values lower than 0.05 were considered signiﬁcant (*Po0.05, **Po0.01, and ***Po0.001).
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previous ﬁndings showing that autophagic ﬂux is beneﬁcial
for host degradation of MRSA (Amano et al., 2006; Mauthe
et al., 2012). With regard to the role of IsaB in autophagic
ﬂux, our study found that BafA1 largely rescued the survival of
isaB deletion strain in THP-1 cells, whereas autophagy
inhibition by RNA interference had minimal effects on
bacterial survival in the cells. BafA1, an inhibitor of vacuolar
H+-ATPase, has been found to inhibit the acidiﬁcation of
lysosomes and to further block the fusion of autophagosomes
with lysosomes (Klionsky et al., 2008). IsaB expression in S.
aureus is induced in acidic environments (pH 4–5) (Garzoni
et al., 2007; Mackey-Lawrence and Jefferson, 2013b),
implying that elevated IsaB in MRSA may prevent lysosomal
acidiﬁcation and indirectly impair autophagic ﬂux. However,
further study is required to determine the detailed
mechanisms of IsaB on autophagy regulation in host cells.
Autophagy modulates proinﬂammatory transcription factors
and IL-1β activation and secretion to suppress inﬂammation
(Dupont et al., 2011; Harris et al., 2011; Yuk and Jo, 2013).
Our results show that IsaB induces the production of the
inﬂammatory cytokines TNF-α and IL-8, but not the activation
or secretion of IL-1β (data not shown), suggesting that IsaB-
inhibited autophagic ﬂux may enhance the ability of
proinﬂammatory transcription factors to augment inﬂamma-
tion. In addition to autophagy, immune cell death is also
involved in pathogenic factor–induced inﬂammation. Our
results also show that strains expressing high levels of IsaB
induce apoptosis in macrophages. IsaB expression is elevated
when S. aureus is internalized into human cells or exposed to
neutrophils (Voyich et al., 2005; Garzoni et al., 2007).
Neutrophils are the immune cells that immediately migrate to
infected sites to kill S. aureus, mainly through opsono-
phagocytosis (van Kessel et al., 2014), implying that IsaB may
have a role in opsonophagocytosis of neutrophils. Never-
theless, understanding the role of IsaB in neutrophil-mediated
opsonophagocytosis will require further study aimed at
clarifying these missing links.
In this study, we observed elevated levels of IsaB in
transmissible MRSA. Elevated IsaB inhibits host autophagic
ﬂux and promotes MRSA virulence. Immunization with IsaB
effectively protects mice from skin lesions caused by MRSA
(1). Of note, IsaB is a secreted or cell surface virulence factor
that is widely expressed in most strains of S. aureus, including
MRSA and methicillin-sensitive S. aureus (Mackey-Lawrence
et al., 2009; Mackey-Lawrence and Jefferson, 2013a). Thus,
our study suggests that IsaB is a potential target for preventing
or treating S. aureus infection, and this could greatly beneﬁt
human health.
MATERIALS AND METHODS
Isolation of the transmissible MRSA252 strain
Female ICR mice (3 to 6 weeks old; Harlan, Placentia, CA)
were maintained at the University of California, San Diego in
accordance with the institutional guidelines. MRSA252 (25 μl in
phosphate-buffered saline; 1×107 colony-forming units ), or 25 μl of
phosphate-buffered saline, used as a negative control, was subcuta-
neously injected into the central portion of the left ear of mice. Infected
ear skin was harvested and homogenized on day 3 after infection. The
homogenate was plated on tryptic soy agar to pick bacterial colonies
for further experiments. The MRSA252 strain before host transmission
was named MRSA(0), and MRSA252 after one generation of host
transmission was named MRSA(1). All animal experiments were
approved by the institutional animal care and use committee of the
University of California, San Diego.
Bacterial and cell culture
The MRSA252 strain, WT S. aureus 10833 strain, isaB deletion
10833ΔisaB::erm strain (with erythromycin antibiotic), and clinical
MRSA isolates were cultured in 3% (w/v) trypticase soy broth (Sigma-
Aldrich, St Louis, MO) under aerobic conditions at 37 °C overnight
with shaking (250 r.p.m.). Human macrophage-like THP-1 cells were
cultured in RPMI-1640 medium (Invitrogen, Carlsbad, CA) and
infected with bacteria for assessment of bacterial survival, inﬂam-
matory cytokine production, and immunoblotting. Mouse embryonic
ﬁbroblast cells that stably express GFP-MAP1LC3 and human
cervical cancer HeLa cells transfected with RFP-GFP-MAP1LC3,
LAMP1-RFP, or GFP-MAP1LC3 were cultured in DMEM (Invitrogen)
and either infected with bacteria or treated with recombinant IsaB;
autophagic ﬂux and localization were then assessed with confocal
microscopy. Detailed information about bacteria, antibodies, cyto-
kines, plasmids, and recombinant IsaB is given in the Supplementary
Materials and Methods.
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